A detailed history of Mgo One Seven LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Mgo One Seven LLC holds 3,406 shares of VRTX stock, worth $1.71 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
3,406
Previous 3,221 5.74%
Holding current value
$1.71 Million
Previous $1.51 Million 4.97%
% of portfolio
0.07%
Previous 0.07%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 15, 2024

BUY
$460.0 - $505.78 $85,100 - $93,569
185 Added 5.74%
3,406 $1.58 Million
Q2 2024

Aug 07, 2024

BUY
$392.81 - $485.53 $627,710 - $775,876
1,598 Added 98.46%
3,221 $1.51 Million
Q1 2024

May 14, 2024

BUY
$407.69 - $446.08 $164,706 - $180,216
404 Added 33.14%
1,623 $678,000
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $139,258 - $166,736
406 Added 49.94%
1,219 $495,000
Q3 2023

Nov 03, 2023

SELL
$338.18 - $362.46 $41,257 - $44,220
-122 Reduced 13.05%
813 $282,000
Q2 2023

Aug 11, 2023

SELL
$314.42 - $351.91 $118,536 - $132,670
-377 Reduced 28.73%
935 $329,000
Q1 2023

May 08, 2023

BUY
$283.23 - $323.1 $30,872 - $35,217
109 Added 9.06%
1,312 $413,000
Q4 2022

Jan 25, 2023

BUY
$285.76 - $321.48 $66,867 - $75,226
234 Added 24.15%
1,203 $0
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $22,454 - $25,053
82 Added 9.24%
969 $519,000
Q2 2022

Aug 10, 2022

SELL
$234.96 - $292.55 $17,622 - $21,941
-75 Reduced 7.8%
887 $250,000
Q1 2022

May 13, 2022

BUY
$221.42 - $260.97 $213,006 - $251,053
962 New
962 $251,000
Q1 2019

Apr 09, 2019

SELL
$163.73 - $194.7 $31,927 - $37,966
-195 Closed
0 $0
Q4 2018

Jan 24, 2019

BUY
$151.91 - $192.21 $29,622 - $37,480
195 New
195 $32,000
Q3 2018

Oct 09, 2018

SELL
$167.73 - $192.74 $33,713 - $38,740
-201 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$151.6 - $177.13 $606 - $708
-4 Reduced 1.95%
201 $33,000
Q4 2017

Feb 16, 2018

BUY
$137.28 - $155.55 $28,142 - $31,887
205
205 $31,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $129B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Mgo One Seven LLC Portfolio

Follow Mgo One Seven LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mgo One Seven LLC, based on Form 13F filings with the SEC.

News

Stay updated on Mgo One Seven LLC with notifications on news.